绝经前2型糖尿病女性的骨髓脂肪增多及其与骨组织形态计量学的关系
横断面研究纳入26例绝经前2型糖尿病女性,按HbA1c<7%和>7%分组,评估骨髓脂肪、骨组织形态计量学与血糖控制的关系。血糖控制差与骨髓脂肪细胞增生和肥大及骨体积分数降低相关,胰岛素使用可能刺激骨髓脂肪扩张,二甲双胍则相反。
要点
- 血糖控制差与骨髓脂肪细胞增生、肥大及骨体积分数降低相关。
- Ad.N/BS与HbA1c正相关,与骨样厚度负相关。
- 胰岛素使用与骨髓脂肪参数正相关,二甲双胍使用呈负相关。
核心结论
- 血糖控制差与骨髓脂肪细胞增生和肥大及骨体积分数降低相关。
- Ad.N/BS与HbA1c正相关,与骨样厚度负相关。
- 胰岛素使用可能刺激骨髓脂肪扩张,二甲双胍可能抑制其扩张。
研究设计与样本
- 横断面研究纳入26例绝经前2型糖尿病女性,按HbA1c<7%分为良好控制组(GC,n=10)和HbA1c>7%分为不良控制组(PC,n=16)。
- 评估骨髓脂肪参数(Ad.N、Ad.Pm、Ad.Ar、Ad.V/Ma.V)及Ad.N/BS,测量骨组织形态计量学静态和动态参数及血清IGF-1。
主要发现
- PC组Ad.N、Ad.Pm、Ad.Ar均高于GC组(均P=0.04)。
- HbA1c与Ad.N/BS正相关(P<0.01),Ad.N/BS与O.Th负相关(P<0.01),与OS/BS负相关(P=0.02)。
- 胰岛素使用与除Ad.N/BS外的所有脂肪细胞参数正相关(P<0.05),二甲双胍使用与这些参数负相关(P<0.05)。
- 骨结构参数与骨髓脂肪参数负相关。
临床怎么用
- 绝经前2型糖尿病女性血糖控制差时需关注骨髓脂肪增多及骨质量下降。
- 胰岛素治疗可能促进骨髓脂肪扩张,二甲双胍可能具有相反作用。
- Ad.N/BS可作为反映血糖控制与骨形成的潜在骨髓脂肪参数。
局限性
- 横断面设计无法推断因果关系。
- 样本量较小(共26例)。
- 单中心研究,结果外推需谨慎。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
CONTEXT: No study has yet evaluated the relationships among bone marrow adiposity (BMA), bone histomorphometry (BH), and glycemic control in premenopausal women with type 2 diabetes (T2DM). OBJECTIVE: We aimed to assess the effect of glycemic control on BMA, correlate the parameters of BH with BMA, and correlate BMA with the use of hypoglycemic agents and with bone mineral density (BMD). METHODS: This was a cross-sectional study that evaluated 26 premenopausal women with T2DM who were divided into groups with HbA1c < 7% (good control [GC], n = 10) and HbA1c > 7% (poor control [PC], n = 16). BMA parameters (adipocyte number [Ad.N], total adipocyte perimeter [Ad.Pm], total adipocyte area [Ad.Ar], percentage adipocyte volume per marrow volume [Ad.V/Ma.V]) and peri-trabecular adipocyte number divided by bone surface (Ad.N/BS) were evaluated. BH static (bone volume fraction [BV/TV], osteoid thickness [O.Th], osteoid surface/bone surface [OS/BS]) and dynamic parameters and serum insulin-like growth factor-1 were measured. BMA data were compared between the GC and PC groups. Correlations were performed. RESULTS: Ad.N, Ad.Pm, and Ad.Ar were higher in PC (all, P = 0.04). HbA1c correlated positively with Ad.N/BS (P < 0.01) and Ad.N/BS correlated negatively with O.Th (P < 0.01) and OS/BS (P = 0.02). Positive and negative correlations were observed between insulin and metformin use, respectively, with all adipocyte parameters except Ad.N/BS (P < 0.05). Structural parameters were negatively correlated with the BMA. BMD of the femoral neck (r = -549, P < 0.01) and total femur (r = -0.502, P < 0.01) were negatively correlated with Ad.V/Ma.V. CONCLUSION: Poor glycemic control is associated with hyperplasia and hypertrophy of BMAs and with lower BV/TV. Ad.N/BS, a new BMA parameter, is correlated with HbA1c and negatively with O.Th. The use of insulin seems to stimulate the expansion of BMA while that of metformin has the opposite effect. These findings suggest that the increase in BMA may play a role in the T2DM bone disease; on the other hand, good glycemic control might help prevent it.
引用
- Andrade VFC, Besen D, Chula DC, et al. Bone Marrow Adiposity in Premenopausal Women With Type 2 Diabetes With Observations on Peri-Trabecular Adipocytes. J Clin Endocrinol Metab. 2021. PMID: 33974069. doi:10.1210/clinem/dgab322
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。